Production

31. Thermo Fisher Scientific North America Single-Use Technologies Capacity Expansion 3/2/2021

    Thermo Fisher Scientific is expanding our single-use manufacturing network globally. Some of the largest investments are taking place at our existing Logan, Utah, and Millersburg, Pennsylvania, sites. We are adding space for clean rooms for the manufacturing and assembly of Thermo Scientific BioProcess Containers and fluid transfer assemblies, investing in 2D and 3D chamber manufacturing equipment, and harmonizing our quality systems and processes.

32. Scaling Up: Increasing Production Capacity While Reducing Costs 11/1/2023

    Medical device companies must meet the demand plan for their devices while managing production costs. Gain valuable insights for scaling up production capabilities efficiently and cost-effectively.

33. How To Select Your DSP Chromatography Technology 10/16/2024

    Watch to explore the differences between the conventional single-column batch method and the multi-column approach for mAb capture.

34. Showcasing A Scalable Downstream Platform For Multiple AAV Serotypes 10/10/2024

    Watch to explore how to maximize AAV full capsid recovery, establish a scalable platform for various serotypes, and utilize analytical tools to measure empty/full capsid ratios and AAV titers.

35. Thermo Fisher Scientific Suzhou, China Manufacturing Site Capabilities 11/2/2018

    Watch this video to learn more about this manufacturing site capabilities, quality management systems, PPI implementation, product expansion, assurance of supply and lead times.

36. Solvent-Free, Fusion-Based Amorphic Dispersion Process 7/11/2024

    Discover a solvent-free, fusion-based process that leverages frictional and shear forces to rapidly convert crystalline drugs and polymers into amorphous solid dispersions (ASDs).

37. Small-Scale Oligonucleotide Synthesizer That Supports Scale Up 2/16/2023

    Learn about a small oligonucleotide synthesizer with big impact that features a user-friendly interface, compact footprint, and more. This small scale system is user friendly and supports scale up.

38. Improve The Bioavailability Of Poorly Soluble Drugs 3/19/2024

    KinetiSol is a fusion-based, solvent-free process that utilizes frictional and shear energies — in a fraction of the time of other amorphous solid dispersion technologies.

39. Intensification Strategies For Upstream, Downstream Processes 3/8/2022

    How do you know if an intensification approach will provide advantages? Three process intensification experts show how various intensification approaches affect outputs using different scenarios.

40. Accelerating Progress: Key Considerations For CDMOs To Maximize Productivity And Scalability 6/29/2021

    Due to the urgent demand for vaccines and treatments, the biopharmaceutical industry is experiencing disruptive changes and increased demand on resources that are requiring a significant operational transformation. To accelerate the delivery of life-saving therapeutics, it is essential to evaluate effective ways to maximize efficiencies and increase capacity while minimizing risk. Flexibility is critical in bioprocessing today to stay up to speed with the quickly shifting needs of the industry.